Pharma Market Case Studies

IQVIA Signal Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections

IQVIA Signal: Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections

FDA & Regulatory Intelligence, Pharma Market Case Studies, Pharma News / Leave a Comment

IQVIA Signal: Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections | Witfire Elite View Witfire Elite Pharma Markets Case Studies Strategy Long Read Pharma Market Case Study Witfire Elite View IQVIA Signal: Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections A data-rich pharma case study on how IQVIA’s early […]

IQVIA Signal: Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections Read More »

FDA’s Digital Liver Break How AI Toxicology Could Change Drug Development Before Phase I

FDA’s Digital Liver Break: How AI Toxicology Could Change Drug Development Before Phase I

FDA & Regulatory Intelligence, Pharma Market Case Studies, Pharma News / Leave a Comment

FDA’s Digital Liver Break: How AI Toxicology Could Change Drug Development Before Phase I | Witfire Elite View Witfire Elite FDA & Regulatory Case Studies Strategy Long Read FDA & Regulatory Intelligence Witfire Elite View FDA’s Digital Liver Break How AI Toxicology Could Change Drug Development Before Phase I FDA accepted the first in silico

FDA’s Digital Liver Break: How AI Toxicology Could Change Drug Development Before Phase I Read More »

The China Biotech Pipeline Grab: How Big Pharma Started Buying Innovation From China

The China Biotech Pipeline Grab: How Big Pharma Started Buying Innovation From China

Pharma Market Case Studies, Pharma News / Leave a Comment

The China Biotech Pipeline Grab: How Big Pharma Started Buying Innovation From China | Witfire Elite View Witfire Elite Pharma Markets Case Studies Strategy Long Read Pharma Market Case Study Witfire Elite View The China Biotech Pipeline Grab How Big Pharma Started Buying Innovation From China A data-heavy pharma case study on how Pfizer, BMS,

The China Biotech Pipeline Grab: How Big Pharma Started Buying Innovation From China Read More »